Newron Pharmaceuticals S.p.A. header image

Newron Pharmaceuticals S.p.A.

NWRN

Equity

ISIN IT0004147952 / Valor 2791431

SIX Swiss Exchange (2024-09-18)

CHF 8.34+2.08%

Newron Pharmaceuticals S.p.A.
UMushroom community rating:

4.75 2 votes No rating yet

NegativeNeutralPositive

About company

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company founded in 1999 and headquartered in Bresso, Italy, with a subsidiary in Morristown, USA. The company is focused on developing novel therapies for patients with diseases of the central and peripheral nervous system. Newron is listed on the SIX Swiss Exchange, the primary market of the Düsseldorf Stock Exchange, and on XETRA. The company is dedicated to expanding its portfolio of products through in-house efforts, as well as through licensing and acquiring novel CNS compounds at various stages of development.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

54.4%1Y

305%3Y

45.0%5Y

Performance

79.8%1Y

82.9%3Y

95.5%5Y

Volatility

185 M

Market cap (USD)

21,063

Daily traded volume (Shares)

8.35 / 8.12

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.75

2 votes

Performance:

3.00

Innovation:

4.75

Society:

4.75

Nature:

4.50

Markus Fässler

Switzerland, 05 Feb 2024

Evenamide, Newron’s innovative drug to treat schizophrenia, has proven safe and effective in use for TRS patients.

Luba Schoenig

Switzerland, 07 Jan 2023

EQUITIES OF THE SAME SECTOR

Kaken Seiyaku KK

Kaken Seiyaku KK Valor: 762167

Annual Return

-50%0%+50%

Risk level

110

-0.20%JPY 3,915.00

KK B.M.L

KK B.M.L Valor: 789977

Annual Return

-50%0%+50%

Risk level

110

0.56%JPY 2,678.00

Towa Yakuhin KK

Towa Yakuhin KK Valor: 248084

Annual Return

-50%0%+50%

Risk level

110

1.06%JPY 2,958.00

Novartis Inc

Novartis Inc Valor: 567514

Annual Return

-50%0%+50%

Risk level

110

0.23%USD 115.97

GSK PLC

GSK PLC Valor: 120042705

Annual Return

-50%0%+50%

Risk level

110

-0.31%USD 42.43

GSK PLC

GSK PLC Valor: 119642297

Annual Return

-50%0%+50%

Risk level

110

-0.34%GBP 16.04

Royalty Pharma PLC

Royalty Pharma PLC Valor: 55041695

Annual Return

-50%0%+50%

Risk level

110

-0.11%USD 28.21

Olaplex Holdings Inc

Olaplex Holdings Inc Valor: 113471584

Annual Return

-50%0%+50%

Risk level

110

5.65%USD 2.62

Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc Valor: 10773079

Annual Return

-50%0%+50%

Risk level

110

0.89%USD 4.52

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1103058

Annual Return

-50%0%+50%

Risk level

110

-1.15%GBP 11.63

SIX

FactSet

Clearbit

Logos provided by Clearbit